Banerjee Subhashis 4
4 · Artiva Biotherapeutics, Inc. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Artiva (ARTV) CMO Subhashis Banerjee Sells 7,037 Shares
What Happened
Subhashis Banerjee, Chief Medical Officer of Artiva Biotherapeutics (ARTV), reported a sale of 7,037 shares on 2026-05-19. The transaction generated gross proceeds of approximately $63,386. The weighted average sale price was $9.0076, with individual trade prices ranging from $8.7404 to $9.0104. According to the filing, these sales were automatic sell-to-cover transactions to satisfy tax withholding obligations tied to the vesting/release of restricted stock units, not discretionary open-market selling.
Key Details
- Transaction date: 2026-05-19
- Transaction type/code: Sale (S) — reported as open market or private sale; described in footnote as sell-to-cover for tax withholding
- Shares sold: 7,037
- Weighted average sale price: $9.0076; price range: $8.7404–$9.0104
- Gross proceeds: ~$63,386
- Shares owned after transaction: Not disclosed in the provided filing
- Footnotes: F1 — sale was automatic to cover tax withholding for vested RSUs; F2 — weighted average and price range provided; full per-price breakdown available upon request to SEC/issuer/holders
- Filing timeliness: Report filed same day as the transaction (timely)
Context
Sell-to-cover transactions are routine administrative sales to satisfy tax withholding when restricted stock units vest; they do not necessarily indicate the insider's view of the company. This was not a purchase or an exercise followed by a sale; it was a tax-withholding sale tied to compensation.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-05-19$9.01/sh−7,037$63,386→ 144,963 total
Footnotes (2)
- [F1]The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The weighted average sale price for the transaction reported was $9.0076, and the range of prices were between $8.7404 and $9.0104. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.